期刊文献+

Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis 被引量:6

Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis
原文传递
导出
摘要 Objective: Many investigations have studied the associations between matrix metalloproteinase-9 (MMP-9) C1562T polymorphisms and coronary artery disease (CAD). However, the conclusions of these studies were incon- sistent. Therefore, this study was aimed at clarifying the association between MMP-9 C1562T polymorphisms and CAD in a large-scale meta-analysis. Methods: The PubMed and Embase databases were retrieved to collect all pub- lications on the association between MMP-9 C1562T polymorphisms and CAD. Then the odd ratios (ORs) and 95% confidence intervals (95% CIs) for C1562T TT+TC versus CC genotype between CAD and the control groups were evaluated. Subgroup analysis was also performed according to different races. The meta-analysis was performed by Stata 10.0. Results: Sixteen case-control studies were included in our meta-analysis, involving 11032 CAD patients and 4628 non-CAD controls. Compared with C allele carriers, East Asian T allele carriers TT+TC had a significantly higher risk of CAD (OR=1.43; 95% CI: 1.03-1.99; P=0.031); however, there were no significant associations in Western populations (OR=1.06; 95% CI: 0.96-1.18; p=0.240) or West Asians (OR=1.13; 95% CI: 0.75-1.70; P=-0.565). When further analyzing the association between C1562T polymorphisms and myocardial infarction (MI, the most serious type of CAD), the risk of TT+TC genotype versus CC genotype for MI was significantly higher for the overall (OR=1.21; 95% C1: 1.04-1.40; P=0.012) and for East Asians (OR=1.58; 95% C1: 1.26-1.97; P=0.000) but not in Western populations (OR=1.12; 95% CI: 0.99-1.26; P=0.078). Conclusions: Our meta-analysis suggested an obvious ethnic difference in the association between MMP-9 C1562T polymorphisms and CAD. MMP-9 C1562T polymorphism was significantly related to CAD in East Asians. However, no significant associations were observed in either West Asians or Western populations.
出处 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2014年第3期256-263,共8页 浙江大学学报(英文版)B辑(生物医学与生物技术)
  • 相关文献

参考文献38

  • 1Alp, E., Menevse, S., Tulmac, M., et al., 2009. Lack of asso- ciation between matrix metalloproteinase-9 and endothe- lial nitric oxide synthase gene polymorphisms and coro- nary artery disease in Turkish population. DNA Cell Biol., 28(7):343-350. [doi: 10.1089/dna.2009.0866].
  • 2Asselbergs, F.W., Reynolds, W.F., Cohen-Tervaert, J.W., et al., 2004. Myeloperoxidase polymorphism related to car- diovascular events in coronary artery disease. Am. J. Med., 116(6):429-430. [doi: 10.1016/j.amjmed.2003.10.025].
  • 3Blankenberg, S., Rupprecht, H.J., Poirier, O., et al., 2003. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardi- ovascular disease. Circulation, 107(12):1579-1585. [doi:10. 1161/01 .CIR.0000058700.41738.12].
  • 4Brown, D.L., Hibbs, M.S., Keamey, M., et al., 1995. Identi- fication of 92-kD gelatinase in human coronary athero- sclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation, 91(8):2125-2131. [doi: 10 1161/01 .CIR.91.8.2125].
  • 5Cho, H.J., Chae, I.H., Park, K.W., et al., 2002. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after pereutaneous coronary intervention. J. Hum. Genet., 47(2):88-91. [doi: 10.1007/s100380200006].
  • 6Demacq, C., de Souza, A.P., Machado, A.A., et al., 2006. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects. Clin. Chim. Acta, 365(1-2):183-187. [doi:10.1016/j.cca.2005.08.017].
  • 7Demaeq, C., Vasconcellos, V.B., Marcaccini, A.M., et al., 2008. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clin. Chem. Lab. Med., 46(1):57-63. [doi:10. 1515/CCLM.2008.014].
  • 8Fallah, S., Seifi, M., Ghasemi, A., et al., 2010. Matrix metal- loproteinase-9 and paraoxonase 1 Q/R192 gene poly- morphisms and the risk of coronary artery stenosis in Iranian subjects. J. Clin. Lab. Anal., 24(5):305-310. [doi: 10.1002/jcla.20406].
  • 9Galis, Z.S., Sukhova, G.K., Lark, M.W., et al., 1994. Increased expression of matrix metalloproteinases and matrix de- grading activity in vulnerable regions of human athero- sclerotic plaques. J. Clin. Invest., 94(6):2493-2503. [doi: 10.1172/JCI117619].
  • 10Ghaderian, S.M., Akbarzadeh Najar, R., Tabatabaei Panah, A.S., 2010. Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coron. Artery Dis., 21(6):330-335. [doi:10.1097/MCA.0b013e32833 ce065].

同被引文献23

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部